Check out your Company Bowl for anonymous work chats.
"By joining forces with Shiel, physicians and patients in the New York-New Jersey region will have broader access to Quest's diagnostic insights and innovations," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics. "The acquisition will also deliver on Quest's strategy to accelerate growth and drive operational excellence through strategically aligned, accretive acquisitions."
We're supporting The National Center on Addiction and Substance Abuse's annual Family Day: Making Everyday Special initiative. Our Chairman, President and CEO, Steve Rusckowski, explains why it's so important.
Half of Americans Tested Misuse Their Prescription Medications, According to Quest Diagnostics Analysis - Read the full release: http://glassdoor.com/slink.htm?key=vQDvo
"This new approach from Quest Diagnostics ... replaces an outmoded approach to estimating levels of the bad cholesterol, LDL. Although that method has been the standard for 45 years, it is inaccurate and misleading in many cases, especially when the patient is not fasting. The old method is being replaced with a more precise view of a patient's LDL-C, which does not require an overnight fast," said Eliot A. Brinton, M.D., FAHA, FNLA, president, Utah Lipid Center in Salt Lake City, member of the board of directors of the National Lipid Association, and past president of the American Board of Clinical Lipidology.
"We are pleased to partner with Montefiore, a premiere academic health system recognized for personalized, accountable care," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics.
"During his four and half years as President and CEO, Steve has demonstrated strong leadership, strategic vision, and an ability to drive results and get things done."
Point-of-care healthcare analytics technology Data Diagnostics, a collaboration between Quest Diagnostics and Inovalon, facilitates better care quality and value-based financial performance. We're proud of this Best in Biz award!
IBM Watson Health and Quest announced the launch of IBM Watson Genomics from Quest Diagnostics, a new service that helps advance precision medicine by combining cognitive computing with genomic tumor sequencing.
At Quest, Women In Leadership's goal is to create a sustainable and competitive advantage for the company by fostering an inclusive community of gender diversity and increasing leadership, educational and networking opportunities for women.
